This review examines the intersection of the HIV and SARS-CoV-2 pandemics. People with
HIV (PWH) are a heterogeneous group that differ in their degree of immune suppression …

Abstract Purpose of Review In this review, we examine the intersection of the HIV and
COVID-19 epidemics with focus on COVID-19-related health outcomes and risk factors for …

Objectives Available data show that COVID-19 vaccines may be less effective in people
living with HIV (PLWH) who are at increased risk for severe COVID-19. This meta-analysis …

The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), has captivated the globe's attention since its emergence in 2019. This highly …

Background: The immunogenicity and safety of COVID-19 vaccines among people living
with human immunodeficiency virus (PLWH) are unclear. We aimed to evaluate the …

This study aimed to investigate the immunogenicity to SARS‐CoV‐2 and evasive
subvariants BA. 4/5 in people living with HIV (PLWH) following a third booster shot of …

The safety and efficacy of COVID-19 vaccines in the elderly, a high-risk group for severe
COVID-19 infection, have not been fully understood. To clarify these issues, this prospective …

Objective: To evaluate the potential factors for predicting seroconversion due to the
coronavirus disease 2019 (COVID-19) vaccine in people living with HIV (PLWH). Method …

Objectives: People with HIV (PWH) experience a greater risk of morbidity and mortality
following COVID-19 infection, and poorer immunological responses to several vaccines. We …

To quantify the pooled rate and risk ratio of seroconversion following the uncomplete,
complete, or booster dose of COVID-19 vaccines in patients living with HIV. PubMed …